Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

A young Black boy sits on the floor of a living room holding a video game controller and concentrated on his game
News
Virtual Gaming May Enhance Working Memory for Youth With ADHD
05/17/2024
Brionna Mendoza
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented...
05/17/2024
Psych Congress Network
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network

Advertisement

A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
TD Has ‘Severe Impact’ on Patients and Caregivers
News
TD Has ‘Severe Impact’ on Patients and Caregivers
05/10/2024
Evi Arthur
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was...
05/10/2024
Psych Congress Network
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
News
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
05/07/2024
Evi Arthur
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for...
05/07/2024
Psych Congress Network

Advertisement

woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
brain imaging
News
Overlooked Concussion in Children May Cause Mental Health Comorbidities
05/02/2024
Meagan Thistle
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/02/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network

Advertisement

FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use